A digital platform to help find and enroll patients in clinical trials for rare kidney diseases
A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases
This study is working on a new mobile app called Arkana Connect™ to help doctors find and enroll patients with rare kidney diseases in clinical trials more easily, so that those patients can get the best possible treatment options.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nephropathology Associates NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10930152 on NIH RePORTER |
What this research studies
This research aims to create a digital platform that enhances the identification and enrollment of patients in clinical trials specifically for rare kidney diseases. By leveraging advanced nephropathology insights, the platform will streamline the recruitment process, which is often hindered by the complexity of these conditions. The approach involves utilizing a mobile app, Arkana Connect™, that allows clinicians to track patient biopsies and access pathology reports, facilitating better communication and patient matching. This innovative method is designed to improve the efficiency of clinical trials and ensure that patients with rare kidney diseases are accurately identified and enrolled.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rare kidney diseases who may benefit from participation in clinical trials.
Not a fit: Patients with common kidney diseases or those not eligible for clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to clinical trials for patients with rare kidney diseases, leading to better treatment options.
How similar studies have performed: Other research has shown success with digital platforms for patient recruitment in clinical trials, indicating that this approach has potential for effectiveness.
Where this research is happening
Little Rock, United States
- Nephropathology Associates — Little Rock, United States (Active)
Researchers
- Principal investigator: Larsen, Christopher P — Nephropathology Associates
- Study coordinator: Larsen, Christopher P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.